Equities

Pivot Pharmaceuticals Inc

Pivot Pharmaceuticals Inc

Actions
  • Price (EUR)0.232
  • Today's Change-0.022 / -8.66%
  • Shares traded0.00
  • 1 Year change-23.93%
  • Beta--
Data delayed at least 15 minutes, as of Jun 17 2019 11:30 BST.
More ▼

Key statistics

As of last trade, Pivot Pharmaceuticals Inc (NPAT:BER) traded at 0.232, 141.67% above the 52 week low of 0.096 set on Mar 11, 2019.
52-week range
Today
0.096Mar 11 20190.412Aug 10 2018
Markit short selling activity
Low
Med
High
Open0.227
High0.232
Low0.227
Bid0.232
Offer0.261
Previous close0.2540
Average volume6.78k
Shares outstanding152.38m
Free float135.59m
P/E (TTM)--
Market cap56.38m CAD
EPS (TTM)-0.1360
CAD
Data delayed at least 15 minutes, as of Jun 17 2019 11:30 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.